List of insiders holdings for KalVista Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management EG LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management III LLC Koh Bong Y Shah Nimish P 10% Owner | 2025-04-11 17:22:07 | 0 5,303,985 | 5,303,985 | Form 4 |
| 2 | InterWest Management Partners IX LLC InterWest Partners IX LP GIANOS PHILIP T ORONSKY ARNOLD L Kliman Gilbert H Holmes W Stephen Kjellson Nina S Pepper Douglas A CLEVELAND BRUCE A NASR KHALED 10% Owner | 2016-06-23 17:29:03 | 4,619,195 0 | 4,619,195 | Form 13D |
| 3 | NOHRA GUY P Director | 2015-04-14 17:22:50 | 0 4,343,550 | 4,343,550 | Form 4 |
| 4 | ACMP IV LLC ACP IV L.P. JANNEY DANIEL 10% Owner | 2016-06-24 16:16:50 | 4,343,550 0 | 4,343,550 | Form 13D |
| 5 | Shah Rajeev M. Director 10% Owner | 2017-10-16 16:31:07 | 0 1,441,070 | 1,441,070 | Form 4 |
| 6 | Vivo Ventures VI LLC Vivo Ventures Fund VI L.P. VIVO VENTURES VI AFFIILATES FUND L.P. 10% Owner | 2022-02-11 17:28:19 | 1,383,179 0 | 1,383,179 | Form 13G |
| 7 | Venrock Healthcare Capital Partners II L.P. VHCP Co-Investment Holdings II LLC VHCP Management II LLC Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Koh Bong Y Shah Nimish P 10% Owner | 2020-02-14 16:07:48 | 986,173 0 | 986,173 | Form 13G |
| 8 | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 2025-08-25 19:46:11 | 712,358 0 | 712,358 | Form 4 |
| 9 | Crockett Thomas Andrew CEO | 2024-02-21 21:41:48 | 395,394 0 | 395,394 | Form 4 |
| 10 | Audhya Paul K. CHIEF MEDICAL OFFICER | 2025-08-25 19:45:30 | 207,341 0 | 207,341 | Form 4 |
| 11 | Yea Christopher CHIEF DEVELOPMENT OFFICER | 2025-08-25 19:46:56 | 183,381 0 | 183,381 | Form 4 |
| 12 | Sweeny Nicole Chief Commercial Officer | 2025-08-25 21:33:50 | 116,271 0 | 116,271 | Form 4 |
| 13 | Feener Edward P. CHIEF SCIENTIFIC OFFICER | 2024-05-21 17:59:02 | 116,214 0 | 116,214 | Form 4 |
| 14 | White Thomas Michael See Remarks | 2015-04-08 21:19:26 | 105,506 0 | 105,506 | Form 3 |
| 15 | Gravett David M. VP, Research & Development | 2016-01-05 16:07:23 | 100,000 0 | 100,000 | Form 4 |
| 16 | Piekos Brian Chief Financial Officer | 2025-02-25 20:35:13 | 80,000 0 | 80,000 | Form 4 |
| 17 | Ramiya Premchandran Vice President of Supply Chain | 2016-01-05 16:05:25 | 60,586 0 | 60,586 | Form 4 |
| 18 | Saul David Joseph Director | 2016-02-02 17:06:31 | 56,000 0 | 56,000 | Form 4 |
| 19 | Lewis Hayley See Remarks | 2015-08-05 16:26:10 | 33,181 0 | 33,181 | Form 4 |
| 20 | Clapper David M Director | 2015-08-05 16:30:42 | 29,000 0 | 29,000 | Form 4 |
| 21 | Katkin Keith Director | 2015-08-05 16:28:56 | 29,000 0 | 29,000 | Form 4 |
| 22 | Smith Michael David Senior VP, Development | 2022-05-19 16:59:11 | 25,800 0 | 25,800 | Form 4 |
| 23 | Maetzel Andreas Senior Vice President, Medical | 2021-05-28 17:20:55 | 25,000 0 | 25,000 | Form 4 |
| 24 | Reid Laurence Director | 2024-11-26 16:41:52 | 17,000 0 | 17,000 | Form 4 |
| 25 | Zadno Reza Director | 2015-08-05 16:25:24 | 15,750 0 | 15,750 | Form 4 |
| 26 | Unkart Edward W Director | 2024-10-04 16:06:15 | 10,000 0 | 10,000 | Form 4 |
| 27 | McKune John See Remarks | 2016-01-05 16:05:25 | 10,000 0 | 10,000 | Form 4 |
| 28 | Fairey William Director | 2024-10-04 16:08:45 | 10,000 0 | 10,000 | Form 4 |
| 29 | Pereira Brian JG Director | 2024-10-04 16:08:14 | 10,000 0 | 10,000 | Form 4 |
| 30 | Stuart Nancy Director | 2024-10-04 16:07:41 | 10,000 0 | 10,000 | Form 4 |
| 31 | Treanor Patrick Director | 2024-10-04 16:07:02 | 10,000 0 | 10,000 | Form 4 |
| 32 | Cha Albert Director | 2023-09-28 16:52:27 | 10,000 0 | 10,000 | Form 4 |
| 33 | Edwards Martin Director | 2021-10-04 16:53:55 | 10,000 0 | 10,000 | Form 4 |
| 34 | SOLAND DANIEL B Director | 2021-10-01 16:56:56 | 10,000 0 | 10,000 | Form 4 |
| 35 | ORONSKY ARNOLD L Director | 2020-10-02 20:35:13 | 7,000 0 | 7,000 | Form 4 |
| 36 | ALDRICH RICHARD Director | 2018-10-05 18:03:47 | 7,000 0 | 7,000 | Form 4 |
| 37 | Resnick Joshua Director | 2017-09-29 20:17:42 | 6,000 0 | 6,000 | Form 4 |
| 38 | Renzi David President & CEO | 2016-11-23 13:35:03 | 0 0 | 0 | Form 4 |
| 39 | RA CAPITAL MANAGEMENT LLC Kolchinsky Peter Director 10% Owner | 2022-08-15 17:12:46 | 0 0 | 0 | Form 13G |
| 40 | RA CAPITAL MANAGEMENT LLC RA Capital Healthcare Fund LP Kolchinsky Peter Director | 2022-08-15 17:12:46 | 0 0 | 0 | Form 13G |
| 41 | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner | 2021-02-16 16:03:37 | 0 0 | 0 | Form 13D |
| 42 | Basta Steven L Director | 2016-11-22 16:14:38 | 0 0 | 0 | Form 4 |
| 43 | Maroney Marcee VP, Clinical Affairs | 2016-11-22 16:13:38 | 0 0 | 0 | Form 4 |
| 44 | Novo Holdings A/S 10% Owner | 2017-10-13 16:56:03 | 0 0 | 0 | Form 13D |